“Heading into 1Q25, we also believe BPMC could be seen as an attractive target for strategic partnerships, which could boost shares,” JP Morgan writes. With Ayvakit’s launch being a major focus for ...

Clearly you can’t visit the sand planet of Arrakis and maybe you wouldn’t want to. It’s hot, it’s dry, and you can’t walk in ...

Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug Nuvectis Pharma, Inc. (NASDAQ: NVCT) stock is trading lower after the company reported ...